Related Experiment Video
Updated: May 26, 2026
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Carcinoma of unknown primary: focused evaluation
1Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. gvaradha@mdanderson.org
Journal of the National Comprehensive Cancer Network : JNCCN
|December 14, 2011
Summary
Managing carcinoma of unknown primary (CUP) requires a focused diagnostic approach. Selective use of tests and research is key to improving patient outcomes and survival.
Area of Science:
- Oncology
- Diagnostic Medicine
Background:
- The management of carcinoma of unknown primary (CUP) has evolved with advanced diagnostics.
- Tailored therapeutics present both opportunities and challenges in CUP care.
Purpose of the Study:
- To recommend a focused diagnostic strategy for CUP.
- To emphasize judicious use of imaging, invasive studies, and pathology.
- To highlight future directions in CUP research and treatment.
Main Methods:
- Clinical presentation-based search for the primary cancer.
- Selective utilization of ancillary diagnostic tests.
- Focus on refining CUP subsets and leveraging genomics/proteomics.
Main Results:
- Exhaustive testing often yields low detection rates and increases patient burden.
- Justification for ancillary tests is crucial for comprehensive patient management.
Conclusions:
- A selective diagnostic approach is recommended for CUP.
- Future efforts should focus on refining CUP subsets and developing innovative therapeutic strategies through international collaboration.